Toripalimab Combined With Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma: an Open-label, Parallel Controlled, Phase IIa Study
Latest Information Update: 29 Jun 2020
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary) ; Toripalimab (Primary)
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Adverse reactions
- 29 Jun 2020 New trial record